Any imbalance of adiponectin from optimal serum levels might have detrimental effects, as indicated across various SARDs, including elevated levels in rheumatoid arthritis (RA) and SLE, and decreased levels in systemic sclerosis (SSc) [32]. This evidence concerns the gene ADIPOQ and rheumatoid arthritis.